Clinical Trial Update: Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-70 RCT Study [Phase 4]

View source ↗

Summary

Clinical trial update on the SCOPE-70 Phase 4 study evaluating low- and moderate-intensity statin therapy for primary prevention in adults over 70 with high LDL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipidemia

Drugs mentioned

• Statin (low- to moderate-intensity) (statin)

Snippet

Sponsor: Yonsei University | Conditions: Healthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular Disease | Phase 4 | Status: RECRUITING